ELVN — Enliven Therapeutics Inc. · $2.11B cap

Enliven Therapeutics Inc. (ELVN) is a biotechnology company listed on US.

Use this ELVN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ELVN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ELVN SEC filings page. Lician reads the product cache first so this HTML stays unique to Enliven Therapeutics Inc. even when a live quote feed is slow.

Enliven Therapeutics Inc. latest statements (FY2025)

Latest cached year on this hub. Full ELVN income, balance, and cash tables.

  • Revenue$0
  • Net Income-$103.7M
  • Total Assets$476.2M
  • Total Debt$0
  • Free Cash Flow-$70.5M